Home » Newsletters » BioWorld Science

BioWorld Science

June 20, 2022

View Archived Issues

PIK3C2B variants impact mTOR pathway and lead to lipid signaling-driven focal epilepsy

Cytokine promotes heart repair after infarct

Alpha-emitting radioimmunotherapy: using throrium-227 and antibody conjugates

CD47 blockade with 225Ac-anti-CD33 radioimmunoconjugate in acute myeloid leukemia

Magmas inhibition as new therapeutic strategy in medulloblastoma

Novel humanized mouse model of posterior fossa A ependymoma

New MRGPRX2 antagonists identified at Bioardis

Chengdu Baiyu Pharmaceutical describes G12C mutant GTPase KRAS inhibitors

2692372 Ontario, Dunad Therapeutics patent tubulin polymerization inhibitors

Anti-glypican-3 antibody-drug conjugates developed at Ardeagen

RP Scherer Technologies patents TROP-2-targeting antibody-drug conjugates

Studies explore asprosin as a target for treating binge eating

Lenire licenses VSN-16R from UCL for fragile X syndrome

Heterozygous mutations in TMEM163 cause hypomyelinating leukodystrophy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...